Biden Administration Pause On Pending Trump-Era Rules Stalls FDA Cannabinoids Guidance Progress

 
• By Malcolm Spicer
  
The already long and winding road to FDA allowing lawful use of cannabinoids in non-drug products has become longer and more winding.
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Cannabis/CBD

More from Ingredients & Safety